Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Erythropoietin-Induced Bone Loss Is Driven By an M-CSF Surge in the Bone Marrow As Assessed By Time-Course Studies in a Murine Model

Anton Gorodov, Albert (Alex) Kolomansky, Nathalie Ben-Califa, Lior Lezerovich, Michelle Piper, Yankel Gabet, Drorit Neumann

Blood (2024) 144 (Supplement 1): 5652.

https://doi.org/10.1182/blood-2024-202999

Published: 2024

Journal Articles

Erythropoietin Treatment in Mice Enriches Bone Marrow Osteoclast Precursors, As Reflected By Increased Macrophage Colony-Stimulating Factor (MCSF) and Elevated Expression of Osteoclast Markers in Monocytes

Anton Gorodov, Albert (Alex) Kolomansky, Michelle Piper, Lior Lezerovich, Nathalie Ben-Califa, Yankel Gabet, Drorit Neumann

Blood (2023) 142 (Supplement 1): 5619.

https://doi.org/10.1182/blood-2023-189546

Published: 2023

Journal Articles

Erythropoietin Administration Delays B Cell Maturation and Promotes B Cell to Erythroid Transdifferentiation in Mice

Albert Kolomansky, Anton Gorodov, Stav Kislev, Nathalie Ben-Califa, Alana Starr, Yankel Gabet, Martina Rauner, Ben Wielockx, Moshe Mittelman, Howard S. Oster, Drorit Neumann

Blood (2022) 140 (Supplement 1): 1241–1242.

https://doi.org/10.1182/blood-2022-167848

Published: 2022

Journal Articles

The Non-Erythropoietic EPO Analogue (Cibinetide) Preserves Bone Mass in Mice

Zamzam Awida, Almog Bachar, Hussam Saed, Anton Gorodov, Nathalie Ben-Califa, Maria Ibrahim, Albert Kolomansky, Jennifer Ana Iden, Liad Graniewitz Visacovsky, Tamar Liron, Sahar Hiram-Bab, Michael Brines, Yankel Gabet, Drorit Neumann

Blood (2021) 138 (Supplement 1): 850.

https://doi.org/10.1182/blood-2021-147204

Published: 2021

Journal Articles

Anti-CD20-Mediated B Cell Depletion Is Associated with Reduced Osteoclastogenic Signals and Bone Mass Preservation: Clinical Observation in Patients with Follicular Lymphoma Supplemented By Animal Studies in a Murine Model

Albert Kolomansky, MD, Irit Kay, MD, Nathalie Ben-Califa, PhD, Anton Gorodov, BSc, Zamzam Awida, BSc, Ofer Sadovnic, MD, Maria Ibrahim, BSc, Tamar Liron, PhD, Sahar Hiram-Bab, PhD, Howard S. Oster, MD PhD, Nadav Sarid, MD, Chava Perry, MD PhD, Yankel Gabet, DMD, PhD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-142295

Published: 2020

Journal Articles

B Cell Specific Knockdown of the Erythropoietin (EPO) Receptor Attenuates EPO-Induced Bone Loss in Mice

Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Nathalie Ben-Califa, PhD, Zamzam Awida, Maria Ibrahim, B.Sc., Tamar Liron, PhD, Sahar Hiram-Bab, PhD, Howard S. Oster, MD PhD, Moshe Mittelman, MD, Martina Rauner, PhD, Ben Wielockx, PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2019) 134 (Supplement_1): 939.

https://doi.org/10.1182/blood-2019-127092

Published: 2019

Journal Articles

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Sahar Hiram-Bab, PhD, Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Nathalie Ben-Califa, PhD, Tamar Liron, PhD, Martina Rauner, PhD, Ben Wielockx, PhD, Moshe Mittelman, MD, Howard S. Oster, MD PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2018) 132 (Supplement 1): 846.

https://doi.org/10.1182/blood-2018-99-111643

Published: 2018

Journal Articles

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Alina Ostrovsky, Nathalie Ben-Califa, PhD, Sahar Hiram-Bab, PhD, Tamar Liron, PhD, Howard S. Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2017) 130 (Supplement 1): 5642.

https://doi.org/10.1182/blood.V130.Suppl_1.5642.5642

Published: 2017

Journal Articles

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Kolomansky Albert, MD, Sahar Hiram-Bab, PhD, Naamit Deshet-Unger, MSc, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 2445.

https://doi.org/10.1182/blood.V128.22.2445.2445

Published: 2016

Journal Articles

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Kolomansky Albert, MD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 5043.

https://doi.org/10.1182/blood.V128.22.5043.5043

Published: 2016

Journal Articles

Erythropoietin Stimulates Bone Resorption Via Direct Activation of the Monocytic Lineage and Via Increased RANKL Production By B Cells and Osteoblasts

Sahar Hiram-Bab, PhD, Naamit Deshet, M.Sc., Tamar Liron, PhD, Moshe Mittelman, MD, Max Gassmann, DVM, Martina Rauner, PhD, Kristin Franke, Ben Wielockx, PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2014) 124 (21): 247.

https://doi.org/10.1182/blood.V124.21.247.247

Published: 2014

Journal Articles

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Mor Gross, Yasmin Haim-Ohana, Miriam C. Souroujon, PhD, Howard S. Oster, MD, PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2013) 122 (21): 1849.

https://doi.org/10.1182/blood.V122.21.1849.1849

Published: 2013

Journal Articles

Krox20/EGR2 deficiency accelerates cell growth and differentiation in the monocytic lineage and decreases bone mass

Yankel Gabet, Sanjeev K. Baniwal, Nathalie Leclerc, Yunfan Shi, Alice E. Kohn-Gabet, Jon Cogan, Alexis Dixon, Marilyn Bachar, Lixin Guo, Jack E. Turman, Jr, Baruch Frenkel

Blood (2010) 116 (19): 3964–3971.

https://doi.org/10.1182/blood-2010-01-263830

Published: 2010

NARROW

Erythropoietin-Induced Bone Loss Is Driven By an M-CSF Surge in the Bone Marrow As Assessed By Time-Course Studies in a Murine Model

Erythropoietin Treatment in Mice Enriches Bone Marrow Osteoclast Precursors, As Reflected By Increased Macrophage Colony-Stimulating Factor (MCSF) and Elevated Expression of Osteoclast Markers in Monocytes

Erythropoietin Administration Delays B Cell Maturation and Promotes B Cell to Erythroid Transdifferentiation in Mice

The Non-Erythropoietic EPO Analogue (Cibinetide) Preserves Bone Mass in Mice

Anti-CD20-Mediated B Cell Depletion Is Associated with Reduced Osteoclastogenic Signals and Bone Mass Preservation: Clinical Observation in Patients with Follicular Lymphoma Supplemented By Animal Studies in a Murine Model

B Cell Specific Knockdown of the Erythropoietin (EPO) Receptor Attenuates EPO-Induced Bone Loss in Mice

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Erythropoietin Stimulates Bone Resorption Via Direct Activation of the Monocytic Lineage and Via Increased RANKL Production By B Cells and Osteoblasts

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Krox20/EGR2 deficiency accelerates cell growth and differentiation in the monocytic lineage and decreases bone mass

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only